Cargando…
Exploration of the personalized immune checkpoint atlas of plasma cell dyscrasias patients using high-dimensional single-cell analysis
Immune checkpoint blockade endows patients with unparalleled success in conquering cancer. Unfortunately, inter-individual heterogeneity causes failure in controlling tumors in many patients. Emerging mass cytometry technology is capable of revealing a multiscale onco-immune landscape that improves...
Autores principales: | Tu, Chenggong, Zheng, Yongjiang, Zhang, Hui, Wang, Jinheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251663/ https://www.ncbi.nlm.nih.gov/pubmed/32319658 http://dx.doi.org/10.3892/or.2020.7587 |
Ejemplares similares
-
Identification of the immune checkpoint signature of multiple myeloma using mass cytometry‐based single‐cell analysis
por: Wang, Jinheng, et al.
Publicado: (2020) -
Telomerase activity in plasma cell dyscrasias
por: Xu, D, et al.
Publicado: (2001) -
Ocular complications of plasma cell dyscrasias
por: Singh, Rohan Bir, et al.
Publicado: (2023) -
COVID-19 vaccine immune response and plasma cell dyscrasia
por: Kleebayoon, Amnuay, et al.
Publicado: (2023) -
Neutrophil Extracellular Traps (NETs) and Hypercoagulability in Plasma Cell Dyscrasias—Is This Phenomenon Worthy of Exploration?
por: Ciepiela, Olga, et al.
Publicado: (2021)